What some of you may fail to realize inside this conversation is that we are targeting the US and why we gone down the track of FDA approvals in the US - its all about exposure and if some of you think that the bigger players in the US market and the Yanks look at the Aussie sharemarket market you may be mistaken- yes of course they can call their brokers and put a buy order in on DXB but clearly they are not- There is also Canadian TSX and other options - Its all about marketing which some companies do so well - in the meantime lets just get through the patient trials and build a stronger case
now a dual listing
we are all entitled to our own opinions - ill leave it at that
GLTA
What some of you may fail to realize inside this conversation is...
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
-0.005(1.28%) |
Mkt cap ! $214.4M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 37.0¢ | $503.5K | 1.322M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 26318 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 170072 | 6 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| DXB (ASX) Chart |